Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 15;8(1):794.
doi: 10.1038/s41598-018-19146-y.

Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy

Affiliations

Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy

Ding Peng et al. Sci Rep. .

Abstract

The outcome of bladder cancer after radical cystectomy is heterogeneous. We aim to evaluate the prognostic value of HALP (hemoglobin, albumin, lymphocyte and platelet) and explore novel prognostic indexes for patients with bladder cancer after radical cystectomy. In this retrospective study, 516 patients with bladder cancer after radical cystectomy were included. The median follow-up was 37 months (2 to 99 mo). Risk factors of decreased overall survival were older age, high TNM stage, high American Society of Anesthesiologists (ASA) grade and low HALP score. The predictive accuracy was better with HALP-based nomogram than TNM stage (C- index 0.76 ± 0.039 vs. 0.708 ± 0.041). By combining ASA grade and HALP, we created a novel index-HALPA score and found it an independent risk factor for decreased survival (HALPA score = 1, HR 1.624, 95% CI 1.139-2.314, P = 0.007; HALPA score = 2, HR 3.471, 95% CI: 1.861-6.472, P < 0.001).The present study identified the prognostic value of HALP and provided a novel index HALPA score for bladder cancer after radical cystectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Cut off value for HALP by X-tile software.
Figure 2
Figure 2
Kaplan-Meier curves for overall survival in patients with bladder cancer according to anemia level, (A) hypoalbuminemia level, (B) platelet to lymphocyte rate (PLR), (C) and HALP (D).
Figure 3
Figure 3
Nomogram for 3-year and 5-year survival.
Figure 4
Figure 4
Calibration curves for 3-year (A) and 5-year (B) survival.
Figure 5
Figure 5
Kaplan-Meier curves for all patients (A), NMIBC patients (B), MIBC patients (C) by HALPA score.

Similar articles

Cited by

References

    1. Clark PE, et al. Bladder cancer. Journal of the National Comprehensive Cancer Network: JNCCN. 2013;11:446–475. doi: 10.6004/jnccn.2013.0059. - DOI - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA: a cancer journal for clinicians. 2017;67:7–30. - PubMed
    1. Babjuk M, et al. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of theBladder: Update 2016. European urology. 2017;71:447–461. doi: 10.1016/j.eururo.2016.05.041. - DOI - PubMed
    1. Alfred Witjes J, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. European urology. 2017;71:462–475. doi: 10.1016/j.eururo.2016.06.020. - DOI - PubMed
    1. Chang, S. S. et al. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. The Journal of urology, 10.1016/j.juro.2016.06.049 (2016). - PubMed

Publication types